Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SKP256 is annotated as a pseudogene related to the 7SK small nuclear RNA gene (RN7SK). Pseudogenes do not encode functional proteins or RNAs but represent noncoding genetic elements derived from ancestral gene duplication or retrotransposition. The canonical RN7SK gene encodes a small nuclear RNA (snRNA) crucial for regulating transcription elongation by sequestration of the P-TEFb complex and maintenance of RNA polymerase II pausing[1][2][3]. The pseudogene RN7SKP256 itself is not known to have functional or disease roles, does not encode any receptor, enzyme, or transporter, and has not been implicated as a direct therapeutic target. As such, there are no known drugs, biomarkers, biological functions, or disease associations for RN7SKP256.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SK small nuclear pseudogene 256 (RN7SKP256).